StapleBio is a bio-tech company that focuses on the research and development of pharmaceuticals based on staple nucleic acid technology.
StapleBio has raised $3.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2024.
StapleBio's investors include Mitsubishi UFJ Capital, Higin Capital, Taiho Pharmaceutical, Summit Pharmaceuticals International, Diamond Medino Capital.
StapleBio is headquartered in Kumamoto, Japan.
StapleBio is a bio-tech company that focuses on the research and development of pharmaceuticals based on staple nucleic acid technology.
StapleBio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"StapleBio — Funding & Investors." VCBacked, April 1, 2024, https://www.vcbacked.co/company/staplebio. Accessed August 15, 2026.
VCBacked. (2024). StapleBio — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/staplebio
{{cite web |title=StapleBio — Funding & Investors |url=https://www.vcbacked.co/company/staplebio |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated